Assessment of Recovery After Adductor Canal Block Analgesia in Unilateral Prosthetic Knee Surgery (NCT05715645) | Clinical Trial Compass
CompletedNot Applicable
Assessment of Recovery After Adductor Canal Block Analgesia in Unilateral Prosthetic Knee Surgery
France130 participantsStarted 2023-04-05
Plain-language summary
The purpose of the study is post-operative recovery from prosthetic knee surgery will be assessed by the proportion of patients entering the Accelerated Rehabilitation After Surgery program eligible for discharge from hospital at 2 days according to the following definition: Chung score ≥ 9 with no intravenous (IV) infusion, solid food, transit restored, no signs of infection and Cumulated Ambulation Score D1 ≥ 5 (if discharged on Day 1), Cumulated Ambulation Score Day 2 ≥ 10 (if discharged on Day 2), or Cumulated Ambulation Score Day 3 ≥ 11/18.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient with a score "American Society of Anesthesiologists" I to III;
* Patient undergoing initial unilateral prosthetic knee replacement surgery for osteoarthritis;
* Patient eligible for analgesia by block of the adductor canal associated with additional infiltration;
* Patient accepting to follow the enhanced recovery program after surgery;
* Patient who signed an informed consent form to participate in the study.
Exclusion Criteria:
* Patient with a known allergy to a study product;
* Patient having undergone previous surgery with a prosthesis on the knee to be operated on;
* Patient with morbid obesity (Body Mass Index \> 40);
* Patient with a pre-existing inability to walk;
* Patient with a history of chronic neuropathic pain in the leg undergoing surgery;
* Patient with heart failure with impaired ejection fraction;
* Patient with a history of drug addiction;
* Patient chronically taking level III analgesics;
* Patient taking gabapentin or pregabalin chronically;
* Patient with severe renal or hepatic impairment;
* Patient with a high level of dependence, defined by level 1 or 2 of the Iso-Ressources Group;
* Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
* Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
* Pregnant or likely to be pregnant (of childbearing age without effective contraception) or breastfeeding;
* P…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Post-operative recovery from knee prosthesis surgery
Timeframe: 3 days
Trial details
NCT IDNCT05715645
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche